Hogy Medical Co.,Ltd. (TYO:3593)
Japan
· Delayed Price · Currency is JPY 4,835.00
+40.00 (0.83%)
Mar 10, 2025, 3:30 PM JST
Hogy Medical Income Statement
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2015 |
| Revenue | 39,362 | 39,100 | 38,981 | 36,778 | 36,504 | 37,232 | Upgrade
|
| Revenue Growth (YoY) | 0.41% | 0.31% | 5.99% | 0.75% | -1.96% | 1.57% | Upgrade
|
| Cost of Revenue | 26,733 | 26,037 | 23,241 | 21,361 | 21,177 | 21,798 | Upgrade
|
| Gross Profit | 12,629 | 13,063 | 15,740 | 15,417 | 15,327 | 15,434 | Upgrade
|
| Selling, General & Admin | 7,969 | 8,322 | 8,436 | 8,476 | 8,788 | 9,056 | Upgrade
|
| Operating Expenses | 8,702 | 8,894 | 9,105 | 9,281 | 9,694 | 10,126 | Upgrade
|
| Operating Income | 3,927 | 4,169 | 6,635 | 6,136 | 5,633 | 5,308 | Upgrade
|
| Interest Expense | -49 | -23 | -29 | -6 | -2 | -1 | Upgrade
|
| Interest & Investment Income | 294 | 307 | 155 | 84 | 123 | 140 | Upgrade
|
| Currency Exchange Gain (Loss) | -28 | -37 | - | -43 | 10 | 36 | Upgrade
|
| Other Non Operating Income (Expenses) | -218 | -171 | -108 | 115 | 223 | 307 | Upgrade
|
| EBT Excluding Unusual Items | 3,926 | 4,245 | 6,653 | 6,286 | 5,987 | 5,790 | Upgrade
|
| Gain (Loss) on Sale of Investments | 1,097 | - | - | - | 1,028 | 1,942 | Upgrade
|
| Gain (Loss) on Sale of Assets | -1 | 40 | - | 1 | 1 | 1 | Upgrade
|
| Asset Writedown | -732 | -209 | -464 | -1 | -28 | -9 | Upgrade
|
| Other Unusual Items | -1 | -1 | - | - | 1 | - | Upgrade
|
| Pretax Income | 4,289 | 4,075 | 6,189 | 6,286 | 6,989 | 7,724 | Upgrade
|
| Income Tax Expense | 1,358 | 1,282 | 1,904 | 1,951 | 2,060 | 2,235 | Upgrade
|
| Earnings From Continuing Operations | 2,931 | 2,793 | 4,285 | 4,335 | 4,929 | 5,489 | Upgrade
|
| Minority Interest in Earnings | - | 11 | 31 | 35 | 30 | 40 | Upgrade
|
| Net Income | 2,931 | 2,804 | 4,316 | 4,370 | 4,959 | 5,529 | Upgrade
|
| Net Income to Common | 2,931 | 2,804 | 4,316 | 4,370 | 4,959 | 5,529 | Upgrade
|
| Net Income Growth | -8.83% | -35.03% | -1.24% | -11.88% | -10.31% | -8.51% | Upgrade
|
| Shares Outstanding (Basic) | 23 | 24 | 24 | 29 | 30 | 30 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 24 | 24 | 29 | 30 | 30 | Upgrade
|
| Shares Change (YoY) | -5.02% | 0.05% | -15.08% | -5.52% | 0.09% | -0.88% | Upgrade
|
| EPS (Basic) | 127.19 | 115.54 | 177.93 | 152.99 | 164.03 | 183.05 | Upgrade
|
| EPS (Diluted) | 127.19 | 115.54 | 177.93 | 152.99 | 164.03 | 183.05 | Upgrade
|
| EPS Growth | -4.01% | -35.06% | 16.30% | -6.73% | -10.39% | -7.70% | Upgrade
|
| Free Cash Flow | 7,783 | 4,431 | 7,858 | 5,453 | -496 | 528 | Upgrade
|
| Free Cash Flow Per Share | 337.73 | 182.59 | 323.95 | 190.91 | -16.41 | 17.48 | Upgrade
|
| Dividend Per Share | 80.000 | 80.000 | 71.000 | 68.000 | 68.000 | 66.000 | Upgrade
|
| Dividend Growth | -38.93% | 12.68% | 4.41% | 0% | 3.03% | 3.13% | Upgrade
|
| Gross Margin | 32.08% | 33.41% | 40.38% | 41.92% | 41.99% | 41.45% | Upgrade
|
| Operating Margin | 9.98% | 10.66% | 17.02% | 16.68% | 15.43% | 14.26% | Upgrade
|
| Profit Margin | 7.45% | 7.17% | 11.07% | 11.88% | 13.58% | 14.85% | Upgrade
|
| Free Cash Flow Margin | 19.77% | 11.33% | 20.16% | 14.83% | -1.36% | 1.42% | Upgrade
|
| EBITDA | 9,815 | 10,776 | 10,252 | 10,251 | 10,182 | 10,591 | Upgrade
|
| EBITDA Margin | 24.94% | 27.56% | 26.30% | 27.87% | 27.89% | 28.45% | Upgrade
|
| D&A For EBITDA | 5,888 | 6,607 | 3,617 | 4,115 | 4,549 | 5,283 | Upgrade
|
| EBIT | 3,927 | 4,169 | 6,635 | 6,136 | 5,633 | 5,308 | Upgrade
|
| EBIT Margin | 9.98% | 10.66% | 17.02% | 16.68% | 15.43% | 14.26% | Upgrade
|
| Effective Tax Rate | 31.66% | 31.46% | 30.76% | 31.04% | 29.47% | 28.94% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.